Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O8AY
|
||||
Former ID |
DIB016338
|
||||
Drug Name |
Combined PR1/WT1 vaccine
|
||||
Synonyms |
Combined PR1/WT1 vaccine (leukemia); Combined PR1/WT1 vaccine (leukemia), NIH; Proteinase 1/Wilms tumor 1 vaccine (leukemia), NIH
|
||||
Drug Type |
Vaccine
|
||||
Indication | Myeloid leukemia [ICD9: 208.9; ICD10:C92] | Phase 2 | [533145] | ||
Company |
National Institutes of Health
|
||||
Target and Pathway | |||||
Target(s) | Leukocyte proteinase-3 | Target Info | [529050] | ||
Wilms' tumor protein | Target Info | [529050] | |||
KEGG Pathway | Transcriptional misregulation in cancer | ||||
NetPath Pathway | FSH Signaling Pathway | ||||
IL5 Signaling Pathway | |||||
Pathway Interaction Database | C-MYB transcription factor networkp73pathway:p73 transcription factor network | ||||
Regulation of Telomerase | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.